Orthofix Medical Inc. Restructuring Charges
Orthofix Medical Inc. (OFIX) reported Restructuring Charges of $9.38 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-02-24
- Orthofix Medical Inc. restructuring charges for the quarter ending 2024-12-31 was $1.31M, a 30.72% increase year-over-year.
- Orthofix Medical Inc. restructuring charges for the quarter ending 2024-09-30 was $505.00K.
- Orthofix Medical Inc. restructuring charges for the quarter ending 2024-06-30 was $5.35M, a 1940.46% increase year-over-year.
- Orthofix Medical Inc. restructuring charges for the quarter ending 2024-03-31 was $2.21M, a 87.86% decline year-over-year.
- Orthofix Medical Inc. restructuring charges for fiscal 2024 was $9.38M, a 697.28% increase from fiscal 2023.
- Orthofix Medical Inc. restructuring charges for fiscal 2023 was $1.18M, a 700.00% increase from fiscal 2022.
- Orthofix Medical Inc. restructuring charges for fiscal 2022 was $147.00K, a 80.11% decline from fiscal 2021.
- Orthofix Medical Inc. restructuring charges for fiscal 2021 was $739.00K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.82M derived: sum of 2 quarters · filed 2026-02-24 | $7.17M derived: sum of 3 quarters · filed 2026-02-24 | $9.38M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $505.00K 10-Q · filed 2025-11-04 | $5.85M derived: sum of 2 quarters · filed 2025-11-04 | $8.06M 10-Q · filed 2025-11-04 | $9.07M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $5.35M 10-Q · filed 2025-08-05 | $7.56M 10-Q · filed 2025-08-05 | $8.56M derived: sum of 3 quarters · filed 2026-02-24 | $8.47M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $2.21M 10-Q · filed 2025-05-06 | $3.22M derived: sum of 2 quarters · filed 2026-02-24 | $3.12M derived: sum of 3 quarters · filed 2026-02-24 | $3.39M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $914.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.18M derived: sum of 3 quarters · filed 2026-02-24 | $1.18M 10-K · filed 2026-02-24 | |
| 2023-09-30 | -$92.00K 10-Q · filed 2024-11-07 | $170.00K derived: sum of 2 quarters · filed 2024-11-07 | $170.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $262.00K 10-Q · filed 2024-08-06 | $262.00K 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | $18.20M 10-K · filed 2024-03-05 | $16.90M 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $147.00K 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | $739.00K 10-K · filed 2024-03-05 | ||||
| 2016-12-31 | $2.00M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |